Cooper Companies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Cooper Companies şirketinin kazançları yıllık ortalama -14.7% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 9.6% oranında artan oldu. Gelirler yıllık ortalama 9.4% oranında artan oldu. Cooper Companies şirketinin öz sermaye getirisi 4.5% olup, net marjı 9.4% dir.

Anahtar bilgiler

-14.7%

Kazanç büyüme oranı

-14.8%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi	12.3%
Gelir büyüme oranı	9.4%
Özkaynak getirisi	4.5%
Net Marj	9.4%
Sonraki Kazanç Güncellemesi	05 Dec 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Cooper Companies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BOVESPA:C1OO34 Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
31 Jul 24	3,804	359	1,527	154
30 Apr 24	3,732	340	1,521	152
31 Jan 24	3,666	291	1,580	145
31 Oct 23	3,593	294	1,530	137
31 Jul 23	3,514	275	1,488	130
30 Apr 23	3,427	288	1,467	122
31 Jan 23	3,380	375	1,350	116
31 Oct 22	3,308	386	1,338	110
31 Jul 22	3,219	431	1,297	107
30 Apr 22	3,139	948	1,238	103
31 Jan 22	3,029	939	1,205	98
31 Oct 21	2,923	2,945	1,142	93
31 Jul 21	2,845	2,916	1,122	93
30 Apr 21	2,660	2,355	1,054	90
31 Jan 21	2,465	2,249	997	93
31 Oct 20	2,431	238	991	93
31 Jul 20	2,441	278	937	91
30 Apr 20	2,542	343	972	91
31 Jan 20	2,672	454	981	88
31 Oct 19	2,653	467	993	87
31 Jul 19	2,613	446	981	86
30 Apr 19	2,594	427	957	87
31 Jan 19	2,571	366	944	87
31 Oct 18	2,533	140	973	85
31 Jul 18	2,443	128	907	81
30 Apr 18	2,339	131	864	76
31 Jan 18	2,230	175	823	72
31 Oct 17	2,139	373	799	69
31 Jul 17	2,096	345	756	68
30 Apr 17	2,055	329	739	67
31 Jan 17	2,016	298	726	67
31 Oct 16	1,967	274	711	65
31 Jul 16	1,904	250	679	63
30 Apr 16	1,851	207	666	64
31 Jan 16	1,801	194	656	64
31 Oct 15	1,797	204	661	65
31 Jul 15	1,810	198	659	67
30 Apr 15	1,780	241	655	66
31 Jan 15	1,758	259	648	66
31 Oct 14	1,718	270	639	66
31 Jul 14	1,661	296	632	64
30 Apr 14	1,640	297	623	63
31 Jan 14	1,611	293	618	61

Kaliteli Kazançlar: C1OO34 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: C1OO34 'nin mevcut net kar marjları (9.4%) geçen yılın (7.8%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: C1OO34 şirketinin kazançları son 5 yılda yılda 14.7% oranında azaldı.

Büyüme Hızlandırma: C1OO34 'un son bir yıldaki kazanç büyümesi ( 30.5% ) 5 yıllık ortalamasını (yıllık -14.7% ) aşıyor.

Kazançlar vs. Sektör: C1OO34 geçen yılki kazanç büyümesi ( 30.5% ) Medical Equipment sektörünün 2.9% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: C1OO34 'nin Özsermaye Getirisi ( 4.5% ) düşük olarak değerlendiriliyor.

Cooper Companies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024

The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024

The Cooper Companies, Inc. to Report Q2, 2024 Results on May 30, 2024

The Cooper Companies, Inc. to Report Q1, 2024 Results on Feb 29, 2024

The Cooper Companies, Inc. to Report Q4, 2023 Results on Dec 07, 2023

The Cooper Companies, Inc. to Report Q1, 2023 Results on Mar 02, 2023

Recent updates

The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024

The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024

The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024

The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. to Report Q2, 2024 Results on May 30, 2024

The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024

Girard Sharp LLP and Sauder Schelkopf LLC Files Lawsuit Against Coopersurgical, Inc. and the Cooper Companies, Inc

The Cooper Companies, Inc. Announces Resignation of Gary S. Petersmeyer from Board of Directors

Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc

Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc

The Cooper Companies, Inc. to Report Q1, 2024 Results on Feb 29, 2024

The Cooper Companies, Inc., Annual General Meeting, Mar 19, 2024

The Cooper Companies, Inc. Announces Retirement of Gary S. Petersmeyer as Director

The Cooper Companies, Inc. Provides Revenue Guidance for the Fiscal Year 2024

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors, Effective December 1, 2023

The Cooper Companies, Inc. to Report Q4, 2023 Results on Dec 07, 2023

The Cooper Companies, Inc. (NasdaqGS:COO) acquired Bakri Postpartum Balloon, Cervical Ripening Balloon, Doppler Blood Flow Monitor portfolio and gynecology surgery markets of Cook Medical Incorporated for $300 million.

The Cooper Companies, Inc. Updates Revenue Guidance for the Year 2023

The Cooper Companies, Inc. Provides Revenue Guidance for the Year 2023

The Cooper Companies, Inc. to Report Q1, 2023 Results on Mar 02, 2023

The Cooper Companies, Inc., Annual General Meeting, Mar 15, 2023

CooperCompanies Declares Cash Dividend, Payable on February 10, 2023

The Cooper Companies, Inc. Initiates Earnings Guidance for the Fiscal Year 2023

The Cooper Companies, Inc. to Report Q4, 2022 Results on Dec 08, 2022

the Cooper Companies, Inc. Appoints Cynthia Lucchese to Board of Directors

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full year 2022

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full Year Year 2022

CooperCompanies Appoints Nicholas Khadder as Its General Counsel and Corporate Secretary

The Cooper Companies, Inc. to Report Q3, 2022 Results on Aug 31, 2022

CooperCompanies Declares Semi-Annual Cash Dividend, Payable on August 11, 2022

The Cooper Companies, Inc. Provides Consolidated Earnings Guidance for the Third Quarter, Fourth Quarter and Full Year of Fiscal 2022

The Cooper Companies, Inc. Provides Revenue Earnings Guidance for the Fiscal Year 2022

The Cooper Companies, Inc. (NYSE:COO) signed a binding letter of intent to acquire Reproductive Health Business of Cook Medical for $880 million.

The Cooper Companies, Inc. to Report Q1, 2022 Results on Mar 03, 2022

The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2022

The Cooper Companies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

CooperCompanies Announces MiSight® Approval from Chinese National Medical Products Administration

The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index

the Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2021

The Cooper Companies, Inc. to Report Q1, 2021 Results on Mar 04, 2021

EssilorLuxottica Société anonyme (ENXTPA:EL) and The Cooper Companies, Inc. (NYSE:COO) agreed to acquire SightGlass Vision from The Cooper Companies, Inc. (NYSE:COO).

CooperCompanies Announces Board Changes

The Cooper Companies, Inc. Votes to Elect Teresa S. Madden to Fill the New Director Position, with Effect from December 1, 2020

The Cooper Companies, Inc. to Report Q4, 2020 Results on Dec 03, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin